| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10220933 | Ophthalmology | 2018 | 10 Pages |
Abstract
Glial autoantibodies (MOG IgG1 or aquaporin-4 IgG) are found in one third of all patients with rON. Aquaporin-4 IgG seropositivity predicts a worse visual outcome than MOG IgG1 seropositivity, double seronegativity, or MS diagnosis. Myelin oligodendrocyte glycoprotein IgG1 is associated with a greater relapse rate but better visual outcomes.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jiraporn MD, John J. MD, PhD, Eoin P. MB, BCh, W. Oliver MB, PhD, Jim P. MS, Brian G. MD, Andrew MD, Vanda A. MD, PhD, Jacqueline A. MD, Jan-Mendelt MD, Claudia MD, B. Mark MD, Orhun MD, Cheryl MD, Sarah M. MS, Grant M. MS, Jessica MA, Sean J. MD,